Importance of the vaporization margin during CO2 laser treatment of oral leukoplakia: A survival study

Objectives The main purpose of this study was to assess the response of oral leukoplakia to CO2 laser vaporization treatment, as well as determining possible factors that may affect recurrence of lesions. Materials and methods A retrospective study was conducted, in which the medical records of patients who had been clinically and histologically diagnosed with oral leukoplakia and treated with CO2 laser between 1996 and 2019 at the Oral Medicine Teaching Unit of the Faculty of Dentistry of the University of Santiago de Compostela were reviewed. Results Fifty-eight patients were included: 36 female and 22 male subjects, with a mean age of 63.7 years old (SD +/- 13.1). The average follow-up time was 57.5 months (SD +/- 57.9). A relapse rate of 52.6% was determined. Of all the studied variables, the margin was the only one for which a statistically significant association with recurrence of lesions was demonstrated (p < 0.05). Conclusion The vaporization of lesions using CO2 laser with a safety margin of at least 3 mm from the clinical limits of OL is a key factor in preventing recurrence.

Automated summary

The main objective of this study was to assess the effectiveness of CO2 laser vaporization treatment for oral leukoplakia and determine the factors that may affect lesion recurrence. A retrospective study was conducted, and it was found that there was a statistically significant association between the margin and lesion recurrence. Maintaining a safety margin of at least 3mm during CO2 laser vaporization is a key factor in preventing recurrence.